Pediatric Cardiovascular Medicine. 2nd Edition Brochure
... Pediatric Cardiovascular Medicine, Second Edition, is the perfect reference for residents, fellows, pediatricians, as well as specialists in pediatric cardiology. ...
... Pediatric Cardiovascular Medicine, Second Edition, is the perfect reference for residents, fellows, pediatricians, as well as specialists in pediatric cardiology. ...
Dilated cardiomyopathy after electrical injury: report of two cases
... Laboratory studies revealed a white blood cell (WBC) count and electrolyte levels within the normal range; the serum creatine kinase (CK) level was 748 U/L, and serum CK-MB isozyme, 2.4% of total CK activity. Results of the routine drug and alcohol screen were negative. Three days after admission, t ...
... Laboratory studies revealed a white blood cell (WBC) count and electrolyte levels within the normal range; the serum creatine kinase (CK) level was 748 U/L, and serum CK-MB isozyme, 2.4% of total CK activity. Results of the routine drug and alcohol screen were negative. Three days after admission, t ...
PHYSICAL FITNESS AND CARDIOVASCULAR ENDURANCE
... • Cardio - the heart – about the size of a fist • The Heart – a hollow organ containing 4 chambers • Septum – wall which divides the heart cavity into a “right heart” & a “left heart” • Right Atrium/Left Atrium – holding tanks for the blood ...
... • Cardio - the heart – about the size of a fist • The Heart – a hollow organ containing 4 chambers • Septum – wall which divides the heart cavity into a “right heart” & a “left heart” • Right Atrium/Left Atrium – holding tanks for the blood ...
Congestive Heart Failure in Dogs
... Congestive heart failure is a broad medical term that means that a dog’s heart cannot deliver sufficient blood to its body. This condition can be caused by a failure of the left side, the right side, or both sides of the heart. When the heart starts to fail, the body can compensate to ensure that ...
... Congestive heart failure is a broad medical term that means that a dog’s heart cannot deliver sufficient blood to its body. This condition can be caused by a failure of the left side, the right side, or both sides of the heart. When the heart starts to fail, the body can compensate to ensure that ...
DIAGNOSIS AND TREATMENT OF HEART FAILURE IN THE
... Aetiology: Anaemia that is severe enough (Hct < 25%) can produce signs and symptoms of congestive heart failure (CHF) without underlying cardiac abnormalities Differential diagnosis: Polycythaemia and a raised haematocrit suggest that breathlessness may be caused by lung disease, cyanotic heart dise ...
... Aetiology: Anaemia that is severe enough (Hct < 25%) can produce signs and symptoms of congestive heart failure (CHF) without underlying cardiac abnormalities Differential diagnosis: Polycythaemia and a raised haematocrit suggest that breathlessness may be caused by lung disease, cyanotic heart dise ...
Electrocardiogram (EKG, ECG) Lab
... of muscle tissue (myocardial infarction). The length of an interval indicates whether an impulse is following its normal pathway. A long interval reveals that an impulse has been slowed or has taken a longer route. A short interval reflects an impulse which followed a shorter route. If a complex is ...
... of muscle tissue (myocardial infarction). The length of an interval indicates whether an impulse is following its normal pathway. A long interval reveals that an impulse has been slowed or has taken a longer route. A short interval reflects an impulse which followed a shorter route. If a complex is ...
Exercise and Ischemia
... ischemic ECG or anginal threshold. Alternately, the upper heart level can be set as the highest non ischemic workload from a Graded Exercise Tolerance (GXT).”1 Typically a patient would undergo a GXT and the point, (heart rate/rate pressure product), at which they developed 1mm of ST depression (as ...
... ischemic ECG or anginal threshold. Alternately, the upper heart level can be set as the highest non ischemic workload from a Graded Exercise Tolerance (GXT).”1 Typically a patient would undergo a GXT and the point, (heart rate/rate pressure product), at which they developed 1mm of ST depression (as ...
Mathematical Models for Cardiac Action Potentials
... The heart is an amazing muscle that pumps five quarts of blood per minute throughout the entire human body. For the heart to do this, it must have a normal heart beat. A cardiac arrhythmia is basically the condition in which the heart's normal rhythm is disrupted. Cardiac arrhythmias continue to be ...
... The heart is an amazing muscle that pumps five quarts of blood per minute throughout the entire human body. For the heart to do this, it must have a normal heart beat. A cardiac arrhythmia is basically the condition in which the heart's normal rhythm is disrupted. Cardiac arrhythmias continue to be ...
Dronedarone in patients with congestive heart failure - MS
... This finding contrasts the results of ATHENA where dronedarone reduced CV mortality.3 Specifically, ATHENA demonstrated in 4628 patients with AF at moderate to high risk for CV events that dronedarone therapy was not associated with increased mortality due to pump failure (HR ¼ 0.95, 95% CI ¼ 0.41–1 ...
... This finding contrasts the results of ATHENA where dronedarone reduced CV mortality.3 Specifically, ATHENA demonstrated in 4628 patients with AF at moderate to high risk for CV events that dronedarone therapy was not associated with increased mortality due to pump failure (HR ¼ 0.95, 95% CI ¼ 0.41–1 ...
Introduction to Cardiovascular System
... Blood Pressure In any chamber Rises during systole Falls during diastole Blood flows from high to low pressure Controlled by timing of contractions Directed by one-way valves Cardiac Cycle and Heart Rate At 75 beats per minute Cardiac cycle lasts about 800 msecs When heart rate ...
... Blood Pressure In any chamber Rises during systole Falls during diastole Blood flows from high to low pressure Controlled by timing of contractions Directed by one-way valves Cardiac Cycle and Heart Rate At 75 beats per minute Cardiac cycle lasts about 800 msecs When heart rate ...
AED Study Guide
... administration of an electric shock to the heart) is usually needed to restore a viable heart rhythm. ...
... administration of an electric shock to the heart) is usually needed to restore a viable heart rhythm. ...
ANSWERS TO CHAPTER 12
... medulla of the brain. This results in increased sympathetic stimulation of the heart, increasing heart rate and stroke volume. ...
... medulla of the brain. This results in increased sympathetic stimulation of the heart, increasing heart rate and stroke volume. ...
Answers to 60 Quiz Questions - Health Professions Institute
... Feedback: Third-degree block does not necessarily result in the heart stopping. Even in the presence of sinus arrest (complete cessation of impulse formation at the SA node), some ectopic focus in the atria or the ventricles often spontaneously takes over the pacemaker function. With a junctional (o ...
... Feedback: Third-degree block does not necessarily result in the heart stopping. Even in the presence of sinus arrest (complete cessation of impulse formation at the SA node), some ectopic focus in the atria or the ventricles often spontaneously takes over the pacemaker function. With a junctional (o ...
Heart Failure Fact Sheet
... Lifestyle Changes: Certain lifestyle changes can help alleviate symptoms, slow disease progression and improve everyday life. These changes could include quitting smoking, losing or maintaining weight, eating a heart healthy diet, being physically active, managing stress and getting adequate rest. ...
... Lifestyle Changes: Certain lifestyle changes can help alleviate symptoms, slow disease progression and improve everyday life. These changes could include quitting smoking, losing or maintaining weight, eating a heart healthy diet, being physically active, managing stress and getting adequate rest. ...
Heart Failure Fact Sheet
... Lifestyle Changes: Certain lifestyle changes can help alleviate symptoms, slow disease progression and improve everyday life. These changes could include quitting smoking, losing or maintaining weight, eating a heart healthy diet, being physically active, managing stress and getting adequate rest. ...
... Lifestyle Changes: Certain lifestyle changes can help alleviate symptoms, slow disease progression and improve everyday life. These changes could include quitting smoking, losing or maintaining weight, eating a heart healthy diet, being physically active, managing stress and getting adequate rest. ...
Promising results after percutaneous mitral valve repair
... dyspnoea (New York Heart Association (NYHA) grade three) and MR grade three or more, and had been turned down for surgery due to an excessively high risk. RESULTS: MR was reduced in all but one patient, generally from grade 3.5 ± 0.5 to grade 1.4 ± 0.9. A total of four patients (25%) received two cl ...
... dyspnoea (New York Heart Association (NYHA) grade three) and MR grade three or more, and had been turned down for surgery due to an excessively high risk. RESULTS: MR was reduced in all but one patient, generally from grade 3.5 ± 0.5 to grade 1.4 ± 0.9. A total of four patients (25%) received two cl ...
Interventricular Septum Rupture in the Catheterization Laboratory
... with definitive coronary artery bypass graft surgery within 24-72 hours. Due to persistent hypotension, an intra-aortic balloon pump was placed with good diastolic augmentation. ...
... with definitive coronary artery bypass graft surgery within 24-72 hours. Due to persistent hypotension, an intra-aortic balloon pump was placed with good diastolic augmentation. ...
Use of Inotropic Agents in Treatment of Systolic Heart Failure
... Investigation Group (DIG) trial showed that digoxin has no mortality benefit in this population, but helps reduce the frequency of hospitalization with exacerbation of heart failure symptoms [11]. There are still controversies regarding the role of digoxin in the treatment of HFrEF, as β blockers we ...
... Investigation Group (DIG) trial showed that digoxin has no mortality benefit in this population, but helps reduce the frequency of hospitalization with exacerbation of heart failure symptoms [11]. There are still controversies regarding the role of digoxin in the treatment of HFrEF, as β blockers we ...
Salvage One and One-Half Ventricular Repair and Resection of
... one and one-half ventricle repair in this patient, as described in our earlier publication.6 Although extracorporeal membrane oxygenation is a useful tool to manage acute severe postoperative right ventricular failure, it was not used in this case because of the impression that the RV was inadequate ...
... one and one-half ventricle repair in this patient, as described in our earlier publication.6 Although extracorporeal membrane oxygenation is a useful tool to manage acute severe postoperative right ventricular failure, it was not used in this case because of the impression that the RV was inadequate ...
DOCX ENG
... Patients with end stage renal failure (ESRF) have an increased risk of premature cardiovascular disease. Left ventricular (LV) abnormalities, so called 'uremic cardiomyopathy', are associated with poorer outcome. Cardiac magnetic resonance imaging (CMR) accurately defines LV dimensions and identifie ...
... Patients with end stage renal failure (ESRF) have an increased risk of premature cardiovascular disease. Left ventricular (LV) abnormalities, so called 'uremic cardiomyopathy', are associated with poorer outcome. Cardiac magnetic resonance imaging (CMR) accurately defines LV dimensions and identifie ...
Heart Failure Management: Multidisciplinary Care has Intrinsic
... discharge, significantly reduces rehospitalization over 3 months.3 Finally, Ashton and colleagues have demonstrated that achieving defined clinical stability criteria before discharge reduces readmission rates.2 Rich et al. were the first to demonstrate the benefits of MDC in reducing HF rehospitalizati ...
... discharge, significantly reduces rehospitalization over 3 months.3 Finally, Ashton and colleagues have demonstrated that achieving defined clinical stability criteria before discharge reduces readmission rates.2 Rich et al. were the first to demonstrate the benefits of MDC in reducing HF rehospitalizati ...
Standards for Implantation and Follow
... CRM devices are effective at improving quality of life and reducing mortality. Their use is supported by the National Service Framework for Coronary Heart Disease chapter 8, NICE and international guidelines. Although implantation rates across the UK have increased significantly over the past 10 yea ...
... CRM devices are effective at improving quality of life and reducing mortality. Their use is supported by the National Service Framework for Coronary Heart Disease chapter 8, NICE and international guidelines. Although implantation rates across the UK have increased significantly over the past 10 yea ...
Atrial fibrillation management
... launched in the UK in the coming months. The exact place of vernakalant in therapy has not been determined, but it is possible that it could rival first-line therapies in the management of recent-onset AF. However, cost may limit its use in clinical practice. At the time of writing, vernakalant was ...
... launched in the UK in the coming months. The exact place of vernakalant in therapy has not been determined, but it is possible that it could rival first-line therapies in the management of recent-onset AF. However, cost may limit its use in clinical practice. At the time of writing, vernakalant was ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.